Shantanu’s practice covers diverse areas of general corporate, mergers and acquisitions and private equity investments.
He has been representing multinational companies in various cross-border transactions, advising on foreign direct investments, outbound investments, joint ventures, technology transfers and commercial contract issues.
Shantanu’s work experience includes advising Indian and foreign parties on private equity investments in India and on various issues arising out of the exchange control laws, Companies Act and sector specific laws. He is actively involved in advising some of the largest e-commerce companies in the frequently changing legal landscape.
He has special interest in the niche areas of pharmaceuticals and medical devices and has assisted clients in some of the very prominent deals in the past.
Recently, he advised promoters of the Tulip Group in their exit to Perkin Elmer (USA), in what was one of the largest deals in the medical devices space. The transaction was awarded the M&A Deal of the Year (2017) Award by the India Business Law Journal.
In the pharmaceutical space, he has also advised on the investment in a well-known pharmacy chain, overseas investment in a company manufacturing niche drugs for pets, commercial and legal issues involved in the various stages of development and commercial exploitation of a drug, etc.
He has advised recently on large investments in automotive and manufacturing space, leisure and hospitality sector, IT and ITES sector, real estate sector, etc. He has also recently advised on a fairly complex exit of a consortium of private equity investors from an Indian company involved in disputes between the shareholders.
Prior to joining JSA, Shantanu has had the experience of practising before the Supreme Court of India and the High Court of Delhi.